BEDIMPLANTS

Development of novel biomimetic engineered dental implants for periodontal ligament regeneration

Coordinatore	KING'S COLLEGE LONDON    more  Organization address address: Strand city: LONDON postcode: WC2R 2LS contact info Titolo: Mr. Nome: Paul Cognome: Labbett Email: send email Telefono: +44 02078488184 Fax: 442078000000
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	309˙235 €
EC contributo	309˙235 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2013-IEF
Funding Scheme	MC-IEF
Anno di inizio	2014
Periodo (anno-mese-giorno)	2014-05-01   -   2016-04-30

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	KING'S COLLEGE LONDON  Organization address address: Strand city: LONDON postcode: WC2R 2LS contact info Titolo: Mr. Nome: Paul Cognome: Labbett Email: send email Telefono: +44 02078488184 Fax: 442078000000	UK (LONDON)	coordinator	309˙235.20

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'BEDimplants project represents an innovative concept in oral implantology based on a multidisciplinary approach in periodontal regenerative medicine and tissue engineering that has the potential to significantly influence the outcome of medical and dental therapies. The project aims to develop novel biomimetic engineered dental implants (BEDimplants) that self-promote the regeneration of periodontal ligament (PDL) and provide in a single implant therapy the adequate environment to promote specific cell lineages, such as primary human gingival fibroblast (hGF) and dental pulp stem cells (hDPSC), to integrate, differentiate and proliferate within an artificial biomimetic extracellular matrix (aECM). The utilization of natural products and biomolecules present in the native periodontal ECM such as collagen, hyaluronic acid and cell signaling molecules, BMPs and TGFbs, to be grafted onto titanium surfaces is presented as a promising approach to the development of novelty implantable devices that mimic the complexity of ECM which can be reabsorbed or degraded by the organism after their implantation. Furthermore, self-crosslinkable bioactive peptide sequences (RGD and DGEA) can be synthesized and chemically linked to those biomolecules tailoring their biofunctionality and providing a biomimetic three-dimensional aECM-g-Ti scaffold that can be implanted in the presence of the appropriate cell cocktail that fulfill all the requirements of PDL tissue engineering.'